About Us

BD GeneOhm™ products are at the forefront of rapid, nucleic acid-based system development for the detection and identification of infectious agents and genetic variations. Leveraging the advantages of rapid, molecular-based diagnostics, the BD GeneOhm™ line of products assists in transforming health-care by enabling earlier and more definitive clinical decisions that improve both the quality and the cost of patient care. Through these products, we are dedicated to offering laboratories and clinicians state-of-the-art, molecular based tests that can provide results in less than two hours.

The current BD GeneOhm™ commercial product portfolio includes three rapid, amplified nucleic acid-based assays: the BD GeneOhm™ StrepB Assay for rapid detection of Group B Streptococci, the BD GeneOhm™ MRSA Assay for detection of methicillin-resistant Staphylococcus aureus directly from nasal specimens and the BD GeneOhm™ StaphSR Assay for the simultaneous detection and differentiation of methicillin-resistant Staphylococcus aureus and Staphylococcus aureus directly from positive blood cultures.